FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934

For the ~~Securities~~month ~~Exchange Act~~ of ~~1934~~December 2021

For the month of August 2021

Commission File Number: 001-38562

NEW FRONTIER HEALTH CORPORATION (Translation of Registrant’s Name into English)

(Translation of Registrant’s Name into English)

10 Jiuxianqiao Road,

Hengtong Business Park

B7 Building, 1/F

Chaoyang District, 100015

Beijing, China (Address of principal executive office)

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): Yes ¨ No x¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): Yes ¨ No x¨

EXHIBIT INDEX

Exhibit	Description of Exhibit
99.1	Press Release.
99.2	Agreement and Plan of Merger, dated August 4, 2021, by and among Unicorn II Holdings Limited, Unicorn II Parent Limited, Unicorn II Merger Sub Limited and New Frontier Health Corporation.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	New Frontier Health Corporation

	By:	/s/ Roberta Lipson
		Name: Roberta Lipson
		Title: Chief Executive Officer

Date: ~~August 4~~December 2, 2021

Exhibit	Description of Exhibit
99.1	Press Release dated December 2, 2021 titled “New Frontier Health Corporation Announces Extraordinary General Meeting of Shareholders and Solicitation for Warrantholder Consent”.

Filing Compare · New Frontier Health Corp